---
title: Reteplase versus Alteplase for Acute Ischemic Stroke
date: '2024-06-17'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38884332/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20240618181202&v=2.18.0.post9+e462414
source: N Engl J Med
description: 'CONCLUSIONS: Among patients with ischemic stroke within 4.5 hours after
  symptom onset, reteplase was more likely to result in an excellent functional outcome
  than alteplase. (Funded by China Resources Angde Biotech Pharma and others; RAISE
  ClinicalTrials.gov number, ...'
disable_comments: true
---
CONCLUSIONS: Among patients with ischemic stroke within 4.5 hours after symptom onset, reteplase was more likely to result in an excellent functional outcome than alteplase. (Funded by China Resources Angde Biotech Pharma and others; RAISE ClinicalTrials.gov number, ...